MBOT
Microbot Medical Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$1.44
+0.00%Aug 11, 2026, 15:26 UTC
Microbot Medical Inc. reported a second-quarter net loss of $0.08 per share, in line with the Zacks Consensus Estimate and narrower than the year-ago loss of $0.10 per share.
Source:Jun 25, 2026, 12:30 UTC
Microbot Medical Inc. won the Innovative Start-Up Award from Surgical Robotics Technology for its LIBERTY Endovascular Robotic System.
Source:Jun 23, 2026, 12:30 UTC
Microbot Medical announced that a globally recognized academic center in Pennsylvania has adopted its LIBERTY Endovascular Robotic System, expanding the company's footprint in the Northeast U.S.
Source:Jun 18, 2026, 12:30 UTC
Microbot Medical Inc. partnered with Lovell Government Services Inc. to expand access to its LIBERTY endovascular robotic system for federal healthcare systems including the Veterans Health Administration, Military Health System, and Indian Health Service.
Source:Jun 16, 2026, 12:30 UTC
Microbot Medical entered into an agreement with Lovell Government Services to serve federal healthcare systems including the Veterans Health Administration, Military Health System, and Indian Health Service.
Source:Jun 9, 2026, 12:30 UTC
Microbot Medical announced that a major health system in Michigan has adopted its LIBERTY Endovascular Robotic System, marking the first adoption in Michigan and the greater Midwest U.S.
Source:Jun 2, 2026, 12:30 UTC
Microbot Medical Inc. secured its first healthcare system customer in North Carolina to adopt the LIBERTY Endovascular Robotic System.
Source: